Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy

NCT05985278 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Neoplasm

Interventions

DRUG: [ Lu-177]-Catalase

Sponsor

Peking University Cancer Hospital & Institute